NCT07193303Recruiting
Mental Imagery on Upper Extremity Skills
The Immediate Effect of Mental Imagery on Upper Extremity Skills With the Patients of Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 14 Jul 2026
Brief summary (registry, in English)
Parkinson's disease (PD) is the second most common neurodegenerative disease, characterized pathologically by the progressive loss of dopaminergic neurons in the substantia nigra and clinically by the presence of motor symptoms such as bradykinesia, resting tremor, and/or rigidity. Among the motor deficits frequently observed in PD, patients are known to frequently report difficulties with manual dexterity. Many upper extremity and manual dexterity deficits are present in PD. Motor imagery (MI) is the imaginal execution of motor activities or the activation of specific muscles in the absence of any explicit feedback. This area of rehabilitation has been shown to be effective in improving and developing motor skills in many neurological conditions where patients exhibit motor recognition and execution impairments. MI can be applied at all stages of recovery from PD, is highly effective in movement-related pathologies, and can be performed independently.There is sufficient evidence that MI improves motor performance and learning in individuals with neurological disorders such as multiple sclerosis, stroke, and spinal cord injury. The study was designed to investigate the immediate effects of mental imagery, which is thought to be effective in controlling difficulties in planning and initiating movements in PD, on upper extremity skills. Therefore, the aim of this study was to determine the effect of mental imagery on upper extremity skills in PD.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 12 Sept 2025
- Start date
- 15 May 2026
- Primary completion date
- 15 Dec 2026
- Lead sponsor
- Kahramanmaras Sutcu Imam University
- Diseases
- Parkinson disease
- NCT number
- NCT07193303
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 15 May 2026 to the primary completion date, 15 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals who is taking neuroleptic medications or antidepressants.
Other illness
- Individuals with diagnosed and/or treated psychiatric illnesses who are considered unable to complete the tests.
- Individuals with orthopedic conditions that interfere with manual dexterity tests, such as severe dyskinesia, carpal tunnel syndrome, tendon injuries, or finger amputations; rheumatological conditions such as rheumatoid arthritis and osteoarthritis; and individuals with any neurological condition other than PD.
Who the study is looking for
- Healthy individuals aged 40-75 years, diagnosed with idiopathic PD according to the UK Parkinson's Disease Association Brain Bank criteria by a specialist neurologist, with a Modified Hoehn \& Yahr (m-HY) scale stage ≤4, and with a Mini Mental State Examination score of ≥24 for those with training and ≥18 for those without training, and with no known disease, volunteered to participate in the study.
- PD individuals with no other known neurological and/or systemic disease
- PD individuals without any upper extremity contractures
Age in the registry: 40 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kahramanmaraş Sütçü imam University Coordinator of this site? Confirm its status | Kahramanmaraş | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.